Cylate en es it fr

Cylate Brand names, Cylate Analogs

Cylate Brand Names Mixture

  • No information avaliable

Cylate Chemical_Formula


Cylate RX_link

No information avaliable

Cylate fda sheet

Cylate msds (material safety sheet)

Cylate MSDS

Cylate Synthesis Reference

No information avaliable

Cylate Molecular Weight

291.385 g/mol

Cylate Melting Point

139 oC (hydrochloride salt)

Cylate H2O Solubility

No information avaliable

Cylate State


Cylate LogP


Cylate Dosage Forms

Ophthalmic solution (eye drops)

Cylate Indication

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

Cylate Pharmacology

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

Cylate Absorption

Absorbed following ophthalmic administration.

Cylate side effects and Toxicity

Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

Cylate Patient Information

No information avaliable

Cylate Organisms Affected

Humans and other mammals